Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Acrivon Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +2 vs. Q1 2026
- Shares held
- 21.4M
- +5.17M (+31.8%) vs. Q1 2026
- Total value
- $38.1M
- +$15.5M (+68.8%) vs. Q1 2026
- New holders
- 6
- 21 more added
- Sold out
- 4
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 12,229,396 | $21.8M | 0.19% | +3,888,888+46.6% | Added |
| Sands Capital Ventures, LLC | 2,289,271 | $4.07M | 0.66% | +166,666+7.9% | Added |
| Acadian Asset Management LLC | 1,165,119 | $2.07M | 0.00% | +319,146+37.7% | Added |
| Vanguard Capital Management LLC | 952,008 | $1.69M | 0.00% | +229,973+31.9% | Added |
| Wellington Management Group LLP | 888,130 | $1.58M | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 758,863 | $1.35M | 0.00% | +423+0.1% | Added |
| Two Sigma Investments, LP | 641,498 | $1.14M | 0.00% | +252,103+64.7% | Added |
| Marshall Wace, LLP | 531,856 | $946.7K | 0.00% | −28,580−5.1% | Reduced |
| Bridgeway Capital Management, LLC | 378,900 | $674.4K | 0.01% | +220,000+138.5% | Added |
| Geode Capital Management, LLC | 265,241 | $472.3K | 0.00% | +28,850+12.2% | Added |
| BlackRock, Inc. | 239,112 | $425.6K | 0.00% | +30,173+14.4% | Added |
| Gsa Capital Partners LLP | 200,415 | $357.0K | 0.02% | +13,699+7.3% | Added |
| Vanguard Fiduciary Trust Co | 184,128 | $327.7K | 0.00% | +76,599+71.2% | Added |
| XTX Topco Ltd | 178,239 | $317.3K | 0.00% | +111,357+166.5% | Added |
| Jane Street Group, LLC | 74,648 | $132.9K | 0.00% | −165,043−68.9% | Reduced |
| Northern Trust Corp | 67,202 | $119.6K | 0.00% | +18,300+37.4% | Added |
| State Street Corp | 67,145 | $119.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 43,850 | $78.1K | 0.00% | +9,216+26.6% | Added |
| Citadel Advisors LLC | 41,276 | $73.5K | 0.00% | +41,276 | New |
| Dimensional Fund Advisors LP | 29,332 | $52.2K | 0.00% | +10,968+59.7% | Added |
| Spark Investment Management LLC | 28,300 | $50.4K | 0.10% | +28,300 | New |
| Prelude Capital Management, LLC | 24,015 | $42.7K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 16,407 | $29.2K | 0.00% | −106−0.6% | Reduced |
| Verdad Advisers, LP | 15,054 | $26.8K | 0.03% | +15,054 | New |
| Goldman Sachs Group Inc | 14,920 | $26.6K | 0.00% | +178+1.2% | Added |
| Squarepoint Ops LLC | 13,309 | $23.7K | 0.00% | −14,163−51.6% | Reduced |
| AAFCPAs Wealth Management, LLC | 10,678 | $19.0K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 10,316 | $18.0K | 0.00% | +10,316 | New |
| Marex Group plc | 10,000 | $17.8K | 0.00% | −10,000−50.0% | Reduced |
| Federated Hermes, Inc. | 7,924 | $14.1K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 7,354 | $13.1K | 0.00% | +1,414+23.8% | Added |
| FMR LLC | 6,957 | $12.4K | 0.00% | −2,465−26.2% | Reduced |
| Morgan Stanley | 5,233 | $9.31K | 0.00% | −31,438−85.7% | Reduced |
| Tower Research Capital LLC (TRC) | 1,677 | $2.98K | 0.00% | −2,849−62.9% | Reduced |
| Crews Bank & Trust | 1,044 | $1.86K | 0.00% | +1,044 | New |
| JPMorgan Chase & Co | 751 | $1.34K | 0.00% | +113+17.7% | Added |
| Nisa Investment Advisors, LLC | 584 | $1.04K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 537 | $956 | 0.00% | −97−15.3% | Reduced |
| Redwood Park Advisors LLC | 500 | $890 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 481 | $856 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 400 | $712 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 326 | $580 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 75 | $134 | 0.00% | +1+1.4% | Added |
| Caitong International Asset Management Co., Ltd | 50 | $89 | 0.00% | +46+1,150.0% | Added |
| Citigroup Inc | 6 | $11 | 0.00% | +6 | New |
| Royal Bank of Canada | 30 | $0 | 0.00% | +5+20.0% | Added |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −33,814−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,679−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −4,453−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |